RIO DE JANEIRO, BRAZIL - The global epicenter of the Covid-19 pandemic, registering over 10 million cases in the past 4 months alone, India is facing yet another complicating factor in treating its patients.
Doctors across the country are reporting a rise in cases of a very rare fungal infection among patients recovering or already recovered from the coronavirus.
Mucormycosis is the name of this disease, caused by exposure to . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here